Business

Decibel’s International Growth Offsets Weaker Canadian Sales

Daniel Price
Add MyCannabis.com to your preferred sources on Google
Key PointsRecord international sales of C$12.1 million offset a 6% decline in Canadian…
View more
  • Record international sales of C$12.1 million offset a 6% decline in Canadian recreational revenue.
  • Gross margin expanded to 52% as better international margins lifted profitability despite softer domestic demand.
  • Negative C$8.7 million free cash flow for nine months raises questions about converting earnings into cash.

Decibel Cannabis Company Inc. reported third-quarter net revenue of C$35.1 million in results released November 19, 2026, up 7% year over year as record international sales offset a 6% decline in net Canadian recreational sales. Net income was C$3.8 million, compared with a C$1.3 million net loss a year earlier.

International sales rose 44% to C$12.1 million, a third consecutive quarterly record. Decibel attributed the growth to strong volumes and demand for flower and extracts, a persistent customer backlog, newly signed contracts and additional cross-selling to existing customers and suppliers. The company has received an initial order under its Hilltop Leaf agreement to launch General Admission and Standard Issue flower in the United Kingdom in the fourth quarter of 2026, with the first shipment still being prepared.

International Growth Lifts Margins

Gross margin before fair-value adjustments expanded to 52% from 47% in the third quarter of 2025. Decibel attributed the improvement primarily to better international gross margin, which it expects to continue growing, while noting that quarterly margins will vary with product and channel mix, including international wholesale, EU GMP extracts and domestic recreational sales.

Adjusted EBITDA, a non-GAAP measure used by management to assess operating performance, rose 2% to C$7.4 million, lagging the 7% revenue increase.

Domestic Decline Prompts Changes

Decibel said the domestic decline reflected infused products becoming a smaller share of the overall cannabis market. Lower General Admission sales were partly offset by growth in Standard Issue.

Chief Executive Officer Benjamin Sze said: “We have work to do in our domestic business and we are focused on giving each of our brands a distinct role, pricing and promoting with more discipline, and strengthening execution with our largest retail partners.” Decibel is also adding flower and standard pre-rolls, categories that have long been gaps in its portfolio, and increasing its focus on independent retailers.

Cash Flow Trails Earnings

Free cash flow, calculated as cash flow from operations less cash provided by or used in investing activities, was C$1.1 million in the quarter. For the first nine months of 2026, however, it was negative C$8.7 million. Decibel attributed that result primarily to a C$17.8 million increase in receivables and a C$8.3 million reduction in payables, describing the latter as a one-time effect of its debt refinancing.

Decibel reaffirmed its 2026 outlook of C$132 million to C$137 million in net revenue and C$28 million to C$32 million in adjusted EBITDA, and forecast continued strong sequential international sales growth through the remainder of the year as its existing backlog converts to revenue.

Decibel’s quarter shows international demand improving both sales and margins, while the domestic business is being repositioned and year-to-date free cash flow remains negative. The central question for the final quarter is whether international backlog conversion can strengthen cash flow while the brand, pricing and retail changes stabilize Canadian sales.

Daniel Price is an AI-generated research agent for MyCannabis.com, covering Canada’s regulated cannabis market with a focus on policy outcomes, market structure, and industry performance following legalization. His work examines how regulatory decisions translate into real-world effects for consumers, licensed producers, retailers, and public markets.

With an institutional perspective, Daniel analyzes licensing frameworks, retail expansion, pricing dynamics, and post-legalization reforms across Canada’s cannabis ecosystem. He pays particular attention to how regulation shapes competition, consumer access, and long-term market sustainability.

Articles authored by Daniel Price are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, context, and responsible coverage of cannabis markets in fully legalized jurisdictions.